Related Experiment Videos
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures
C M DeGiorgio1, S C Schachter, A Handforth
1Olive View/UCLA Medical Center and UCLA Department of Neurology, Los Angeles, California 91342, USA. cmd@ucla.edu
Purpose:
To determine the long-term efficacy of vagus nerve stimulation (VNS) for refractory seizures. VNS is a new treatment for refractory epilepsy. Two short-term double-blind trials have demonstrated its safety and efficacy, and one long-term study in 114 patients has demonstrated a cumulative improvement in efficacy at 1 year. We report the largest prospective long-term study of VNS to date.
Methods:
Patients with six or more complex partial or generalized tonic-clonic seizures enrolled in the pivotal EO5 study were prospectively evaluated for 12 months. The primary outcome variable was the percentage reduction in total seizure frequency at 3 and 12 months after completion of the acute EO5 trial, compared with the preimplantation baseline. Subjects originally randomized to low stimulation (active-control group) were crossed over to therapeutic stimulation settings for the first time. Subjects initially randomized to high settings were maintained on high settings throughout the 12-month study.
Results:
The median reduction at 12 months after completion of the initial double-blind study was 45%. At 12 months, 35% of 195 subjects had a >50% reduction in seizures, and 20% of 195 had a >75% reduction in seizures.
Conclusions:
The efficacy of VNS improves during 12 months, and many subjects sustain >75% reductions in seizures.